Yahoo
    Shanghai - Delayed Quote CNY

    Zhejiang Hisun Pharmaceutical Co., Ltd. (600267.SS)

    12.77 -0.13 (-1.01%)
    At close: 3:00:02 PM GMT+8
    Chart Range Bar
    Advanced Chart
    AlphaSpace Chart
    Loading chart for 600267.SS
    • Previous Close 12.90
    • Open 12.78
    • Bid 12.76 x --
    • Ask 12.77 x --
    • Day's Range 12.61 - 12.89
    • 52 Week Range 9.35 - 15.00
    • Volume 26,918,245
    • Avg. Volume 41,952,151
    • Market Cap (intraday) 15.072B
    • Beta (5Y Monthly) --
    • PE Ratio (TTM) 12.16
    • EPS (TTM) 1.05
    • Earnings Date --
    • Forward Dividend & Yield 0.21 (1.63%)
    • Ex-Dividend Date Jun 16, 2026
    • 1y Target Est 9.20

    Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients. It also offers its products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, and orthopedics treatment; nutrition and healthcare; and oncology, ADC small molecule, animal healthcare, and others. The company exports its products to approximately 70 countries worldwide. Zhejiang Hisun Pharmaceutical Co., Ltd. was founded in 1956 and is headquartered in Taizhou, China.

    www.hisunpharm.com

    8,751

    Full Time Employees

    December 31

    Fiscal Year Ends

    Healthcare

    Sector

    Drug Manufacturers - Specialty & Generic

    Industry

    More about Zhejiang Hisun Pharmaceutical Co., Ltd.

    Recent News

    View More
    View More

    Performance Overview

    Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

    YTD Return

    600267.SS
    31.85%
    SSE Composite Index (000001.SS)
    9.09%

    1-Year Return

    600267.SS
    16.32%
    SSE Composite Index (000001.SS)
    9.26%

    3-Year Return

    600267.SS
    31.97%
    SSE Composite Index (000001.SS)
    19.05%

    5-Year Return

    600267.SS
    11.46%
    SSE Composite Index (000001.SS)
    3.13%

    Earnings Trends

    View More

    Earnings Per Share (GAAP)

    Revenue vs. Earnings

    Annual
    Quarterly
    Annual
    Quarterly
    Q1 FY23
    Revenue --
    Earnings 232.3M
    Profit Margin 0.00%

    Q1

    FY09

    Q2

    FY09

    Q3

    FY09

    Q1

    FY23

    0
    200M
    400M
    600M
    800M
    1B
    0.0%
    View More

    Analyst Insights

    View More

    Analyst Price Targets

    9.20 Low
    9.20 Average
    12.77 Current
    9.20

    Analyst Recommendations

    • Strong Buy
    • Buy
    • Hold
    • Underperform
    • Sell
    View More

    Statistics

    View More

    Valuation Measures

    Annual

    • Market Cap

    • Enterprise Value

    • Trailing P/E

    • Forward P/E

    • PEG Ratio (current)

    • Price/Sales (ttm)

    • Price/Book (mrq)

    • Enterprise Value/Revenue

    • Enterprise Value/EBITDA

    Financial Highlights

    Profitability and Income Statement

    • Profit Margin

      13.40%

    • Return on Assets (ttm)

      6.32%

    • Return on Equity (ttm)

      13.32%

    • Revenue (ttm)

      9.15B

    • Net Income Avi to Common (ttm)

      1.23B

    • Diluted EPS (ttm)

      1.05

    Balance Sheet and Cash Flow

    • Total Cash (mrq)

      1.18B

    • Total Debt/Equity (mrq)

      15.82%

    • Levered Free Cash Flow (ttm)

      1.86B

    View More

    Company Insights

    Research Reports

    View More
    View More

    People Also Watch

    600380.SS Joincare Pharmaceutical Group Industry Co.,Ltd.
    10.30 0.00%
    600216.SS Zhejiang Medicine Co., Ltd.
    10.97 +2.33%
    600332.SS Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
    20.25 +1.55%
    600329.SS Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
    42.91 +0.87%
    600196.SS Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
    23.01 +1.01%
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: